LATEST UPDATES

Driver killed, 6 injured in Qazigund accident

Precious Kashmir 22/09/2023

J&K police arrests DySP on charges of corruption, fraud & extortion

Indo Asian News Service 21/09/2023

‘Husband allegedly hammers wife to death in Mendhar’

Precious Kashmir 21/09/2023

India suspends visa services for Canadians

Indo Asian News Service 21/09/2023

PM thanks Lok Sabha MPs for passage of Women’s Reservation Bill

Indo Asian News Service 21/09/2023

Biker dies after collision with vehicle in Qazigund

Precious Kashmir 21/09/2023

All vacant posts in Govt departments to be filled within 6 months: LG Manoj Sinha

Precious Kashmir 19/09/2023

Kokernag Gunfight: LeT Commander Uzair Khan Among Two Militants Killed, Searches To Continue: ADGP Kashmir

Precious Kashmir 19/09/2023

Carpenter dies after falling from rooftop in Budgam village

Precious Kashmir 19/09/2023

PM Modi walks to new Parliament building with cabinet colleagues, MPs

Indo Asian News Service 19/09/2023

Groom plays truant on wedding day in Pulwama

Indo Asian News Service 19/09/2023

India expels Canadian diplomat, citing interference concerns

Indo Asian News Service 19/09/2023
  • Home
  • Front
  • Jammu & Kashmir
    • City
  • Anchor stories
  • Business
  • Sports
  • National
  • World
  • Opinion
    • Edit
    • Interviews
    • Letters
  • Epaper
  • Video
Saturday, September 23, 2023
PRECIOUS KASHMIR
No Result
View All Result
  • Home
  • Front
  • Jammu & Kashmir
    • City
  • Anchor stories
  • Business
  • Sports
  • National
  • World
  • Opinion
    • Edit
    • Interviews
    • Letters
  • Epaper
  • Video
Precious Kashmir
No Result
View All Result
Home Health

New lung cancer pill cuts risk of death by half

Indo Asian News Service by Indo Asian News Service
07/06/2023
in Health
2 min read
New lung cancer pill cuts risk of death by half
FacebookTwitterWhatsappEmail

New York:  A new pill has shown promise of reducing the risk of death from lung cancer by half, according to results of a decade-long global clinical trial.

Taking the drug osimertinib, developed by AstraZeneca, after surgery dramatically reduced the risk of patients dying by 51 per cent, showed results presented at the American Society of Clinical Oncology’s (Asco) annual meeting in Chicago.

Osimertinib, which is marketed as Tagrisso, targets a particular type of lung cancer in patients suffering from non-small cell cancer — the most common type — and showing a particular type of mutation.

Lung cancer is the world’s leading cause of cancer death, accounting for about 1.8 million deaths a year.

“Thirty years ago, there was nothing we could do for these patients,” said lead author Dr Roy Herbst, the deputy director of Yale Cancer Center, was quoted as saying by the Guardian. “Now we have this potent drug.

“Fifty per cent is a big deal in any disease, but certainly in a disease like lung cancer, which has typically been very resistant to therapies.”

The trial involved patients aged between 30 and 86 in 26 countries and looked at whether the pill could help non-small cell lung cancer patients.

Everyone in the trial had a mutation of the EGFR gene — which is found in about a quarter of global lung cancer cases — and accounts for as many as 40 per cent of cases in Asia. An EGFR mutation is more common in women than men, and in people who have never smoked or have been light smokers.

As per the study’s findings, more people diagnosed with lung cancer must be tested for the EGFR mutation

The pill proves to be “practice-changing” and should become the “standard of care” for the quarter of lung cancer patients worldwide with the EGFR mutation, Herbst said.

“This further reinforces the need to identify these patients with available biomarkers at the time of diagnosis and before treatment begins.”

After five years, 88 per cent of patients who took the daily pill after the removal of their tumour were still alive, compared with 78 per cent of patients treated with a placebo, the report said.

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to print (Opens in new window)

Related

Share196Tweet123SendSend
Indo Asian News Service

Indo Asian News Service

ePAPER

Precious Kashmir

Copyright © 2020 Precious Kashmir.

Navigate Site

  • Home
  • About Us
  • Contact Us
  • Advertise with Us
  • Terms of Service

Follow Us

No Result
View All Result
  • Home
  • Front
  • Jammu & Kashmir
    • City
  • Anchor stories
  • Business
  • Sports
  • National
  • World
  • Opinion
    • Edit
    • Interviews
    • Letters
  • Epaper
  • Video

Copyright © 2020 Precious Kashmir.